Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS
VHAQ.WS was delisted on the 23rd of October, 2023.
30 hedge funds and large institutions have $4.16M invested in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
6% less funds holding
Funds holding: 32 → 30 (-2)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
57% less capital invested
Capital invested by funds: $9.69M → $4.16M (-$5.53M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$14.6K |
| 2 |
ASM
ATW SPAC Management
New York
|
+$5.33K |
| 3 |
CS
Clear Street
New York
|
+$4.08K |
| 4 |
CAC
Cowen and Company
New York
|
+$105 |
| 5 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$73 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$15.1K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.9K |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$854 |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$30 |
| 5 |
FTUS
Flow Traders U.S.
New York
|
-$27 |
VHAQ.WS Hedge Fund Activity: Q1 2023 in Review
30 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) for Q1 2023, worth a combined $4.16M — down 57% from $9.69M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of VHAQ.WS and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 6 added.
The largest buyer was Radcliffe Capital Management, adding an estimated $14.6K. The largest seller was K2 Principal Fund, cutting an estimated $15.1K.
- 30 institutional investors held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) as of Q1 2023, down from 32 in Q4 2022.
- Funds reported $4.16M of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share stock for Q1 2023, down 57% quarter-over-quarter.
- 1 fund opened new Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share positions in Q1 2023 and 2 closed out, a net change of -1 holder.
- The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share buyer in Q1 2023 was Radcliffe Capital Management, an estimated $14.6K added.
- The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share seller in Q1 2023 was K2 Principal Fund, an estimated $15.1K sold.
Based on aggregated 13F filings for Q1 2023.